• 4723 Citations
  • 34 h-Index
1991 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where YoungTae Kim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 25 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Uterine Cervical Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Hysterectomy Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Laparoscopy Medicine & Life Sciences
Endometrial Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2019

Genetic profiles associated with chemoresistance in patient-derived xenograft models of ovarian cancer

Li, L. Y., Kim, H. J., Park, S. A., Lee, S. H., Kim, L. K., Lee, J. Y., Kim, S., Kim, Y., Kim, S. W. & Nam, E. J., 2019 Jul 1, In : Cancer Research and Treatment. 51, 3, p. 1117-1127 11 p.

Research output: Contribution to journalArticle

Open Access
Heterografts
Ovarian Neoplasms
Atlases
Neoplasms
Exome

Prognostic significance of CA-125 re-elevation after interval debulking surgery in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy

Lee, Y. J., Chung, Y. S., Lee, J. Y., Nam, E. J., Kim, S. W., Kim, S. & Kim, Y., 2019 Apr 1, In : European Journal of Surgical Oncology. 45, 4, p. 644-649 6 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Antigens
Drug Therapy
Neoplasms
Confidence Intervals
2 Citations (Scopus)

Aberrant uterine leiomyomas with extrauterine manifestation: Intravenous leiomyomatosis and benign metastasizing leiomyomas

Kim, Y. N., Eoh, K. J., Lee, J. Y., Nam, E. J., Kim, S., Kim, S. W. & Kim, Y., 2018 Jul 1, In : Obstetrics and Gynecology Science. 61, 4, p. 509-519 11 p.

Research output: Contribution to journalArticle

Leiomyomatosis
Leiomyoma
Myoma
Recurrence
Leukocytes
4 Citations (Scopus)

An open-label, randomized, parallel, phase ii trial to evaluate the efficacy and safety of a cremophor-free polymeric micelle formulation of paclitaxel as first-line treatment for ovarian cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021)

Lee, S. W., Kim, Y. M., Cho, C. H., Kim, Y., Kim, S. M., Hur, S. Y., Kim, J-H., Kim, B. G., Kim, S. C., Ryu, H. S. & Kang, S. B., 2018 Jan 1, In : Cancer Research and Treatment. 50, 1, p. 195-203 9 p.

Research output: Contribution to journalArticle

Micelles
Paclitaxel
Ovarian Neoplasms
Carboplatin
Safety
10 Citations (Scopus)

Changes in ovarian cancer survival during the 20 years before the era of targeted therapy

Lee, J. Y., Kim, S., Kim, Y., Lim, M. C., Lee, B., Jung, K. W., Kim, J. W., Park, S. Y. & Won, Y. J., 2018 May 29, In : BMC cancer. 18, 1, 601.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Survival
Survival Rate
Endometrioid Carcinoma
Carcinoma